Moreover, taking into account numerous clinical studies and experimental data showing that the pathogenesis of depression is not limited to the brain, but may also result from an impaired cross-talk between the central nervous system and other systems in the body, particularly the immune, endocrine and digestive systems, therapeutic GLP-1 analogs such as exendin-4 or liraglutide can also normalize their functioning in many cases, thus preventing the occurrence of maladaptive brain changes associated with depressive symptoms
Because you're not eating as much, you may not be getting the fiber you need to bulk up stool and keep things moving smoothly, which can also lead to constipation (especially if you're also not drinking enough fluids), says Hamilton
This post covers what the Bridge is, who qualifies, how it interacts with Medicares existing GLP-1 coverage for cardiovascular risk reduction, and how it connects to the previously-announced BALANCE Model
*Correspondence: Jinmin Guo, [email protected]